Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.
von zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. von zur Muhlen C, et al. Among authors: bode c. Circulation. 2008 Jul 15;118(3):258-67. doi: 10.1161/CIRCULATIONAHA.107.753657. Epub 2008 Jun 23. Circulation. 2008. PMID: 18574047
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A, Hofmann H, Bode C, Peter K. von Zur Muhlen C, et al. Among authors: bode c. Atherosclerosis. 2007 Jul;193(1):102-11. doi: 10.1016/j.atherosclerosis.2006.08.048. Epub 2006 Sep 25. Atherosclerosis. 2007. PMID: 16997307
Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C, Fink-Petri A, Salaklang J, Paul D, Neudorfer I, Berti V, Merkle A, Peter K, Bode C, von Elverfeldt D. von zur Muhlen C, et al. Among authors: bode c. Contrast Media Mol Imaging. 2010 Sep-Oct;5(5):268-75. doi: 10.1002/cmmi.384. Contrast Media Mol Imaging. 2010. PMID: 20973112 Free article.
Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
Peter K, Kohler B, Straub A, Ruef J, Moser M, Nordt T, Olschewski M, Ohman ME, Kübler W, Bode C. Peter K, et al. Among authors: bode c. Circulation. 2000 Sep 26;102(13):1490-6. doi: 10.1161/01.cir.102.13.1490. Circulation. 2000. PMID: 11004138
1,418 results